Neuroimaging Biomarkers for Alzheimer’s Disease
Abstract Currently, over five million Americans suffer with Alzheimer’s disease (AD). In the absence of a cure, this number could increase to 13.8 million by 2050. A critical goal of biomedical research is to establish indicators of AD during the preclinical stage (i.e. biomarkers) allowing for earl...
| Main Authors: | , |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
BMC
2019-06-01
|
| Series: | Molecular Neurodegeneration |
| Online Access: | http://link.springer.com/article/10.1186/s13024-019-0325-5 |